The healthcare sector is outperforming the broader market and tech sector in Q4, confirming a substantial capital shift into the defensive industry.
/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
Bristol-Myers has lagged behind the broader S&P 500 Index, and Wall Street remains cautious about this stock.
/Pfizer%20Inc_%20logo%20on%20iPad-by%20Koshiro%20K%20via%20Shutterstock.jpg)
While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock.
1 Nasdaq 100 Stock Worth Your Attention and 2 We Brush Off
/AMGEN%20Inc_%20logo%20on%20website-by%20Jimmy%20Tudeschi%20via%20Shutterstock.jpg)
Amgen has underperformed the Nasdaq over the past year, but analysts are still fairly bullish about the biopharma stock's growth potential.
THOUSAND OAKS, Calif. , Nov. 24, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2025 Global Healthcare Conference at 1:45 p.m. ET on December 3, 2025. Peter Griffith, executive...
THOUSAND OAKS, Calif. , Nov. 24, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 8 th annual Evercore ISI HealthCONx Conference at 10:00 a.m. ET on December 3, 2025. Peter Griffith,...
Global Confirmatory Phase 3 DeLLphi-304 Trial Showed IMDELLTRA Reduced Risk of Death by 40% Compared to Chemotherapy
1 Unpopular Stock That Deserves a Second Chance and 2 We Avoid
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%. December E-mini...